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An effective mechanism for introduction of phenotypic diversity within a bacterial population exploits changes in the length of
repetitive DNA elements located within gene promoters. This phenomenon, known as phase variation, causes rapid activation or
silencing of gene expression and fosters bacterial adaptation to new or changing environments. Phase variation often occurs in
surface-exposed proteins, and in Treponema pallidum subsp. pallidum, the syphilis agent, it was reported to affect transcription
of three putative outer membrane protein (OMP)-encoding genes. When the T. pallidum subsp. pallidumNichols strain genome
was initially annotated, the TP0126 open reading frame was predicted to include a poly(G) tract and did not appear to have a
predicted signal sequence that might suggest the possibility of its being an OMP. Here we show that the initial annotation was
incorrect, that this poly(G) is instead located within the TP0126 promoter, and that it varies in length in vivo during experimen-
tal syphilis. Additionally, we show that TP0126 transcription is affected by changes in the poly(G) length consistent with regula-
tion by phase variation. In silico analysis of the TP0126 open reading frame based on the experimentally identified transcrip-
tional start site shortens this hypothetical protein by 69 amino acids, reveals a predicted cleavable signal peptide, and suggests
structural homology with the OmpW family of porins. Circular dichroism of recombinant TP0126 supports structural homol-
ogy to OmpW. Together with the evidence that TP0126 is fully conserved among T. pallidum subspecies and strains, these data
suggest an important role for TP0126 in T. pallidum biology and syphilis pathogenesis.
Syphilis is a chronic sexually transmitted infection caused bythe spirochete Treponema pallidum subsp. pallidum, a Gram-
negative obligate humanpathogen.Despite being perceived by the
general public to be a disease of the past, syphilis continues to be a
significant burden for global health, with an estimated prevalence
of 36 million cases worldwide and an incidence that exceeds 11
million new cases every year (1). Although most syphilis cases
occur in Latin America, sub-Saharan Africa, and Southeast Asia
(2), including China (3), a worrying resurgence of syphilis has
recently been observed in many developed countries, including
the United States, Canada, Australia, and several European na-
tions (4–8). Congenital syphilis remains a leading cause of still-
births and perinatal deaths among neonates in developing areas
(9, 10), and patients with syphilis are at increased risk for trans-
mission and acquisition of HIV (11, 12).
T. pallidum subsp. pallidum is an extremely successful patho-
gen, characterized by the ability to invade and infect virtually any
organ and elude the host immune response, resulting in pathogen
persistence for decades in infected individuals in the absence of
treatment. Phase variation is one of the means evolved by patho-
genic bacteria to rapidly create phenotypic diversity within a pop-
ulation. When this process influences expression of surface anti-
gens, for example, it can facilitate evasion of the host immune
response (13), influence the affinity of a pathogen for different
host anatomical niches, or foster adaptation to diverse or rapidly
changing microenvironments (14, 15). Variable expression of
opacity (Opa) proteins in Neisseria meningitidis, for example, is
reported to change the pathogen’s tropism for human epithelium,
endothelium, and phagocytic cells (16). At the genetic level, one of
the mechanisms responsible for phase variation is the expansion
and contraction of repetitive nucleotide sequences, such as ho-
mopolymeric tracts [e.g., poly(G) or poly(C) repeats], a phenom-
enon resulting from slipped-strand mispairing of DNA strands
during replication (17, 18).When such homopolymeric repeats of
various lengths are located in a gene promoter between the 35
and 10 binding sites for the  subunit of the RNA polymerase
(RNAP) holoenzyme (14, 19), they canmodulate promoter activ-
ity by increasing or reducing the relative distance between the35
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and10 binding sites. Because of this accordion-likemechanism,
gene transcription occurs when the distance that separates the
35 and10 binding sites is close to 17 nucleotides (nt), which is
optimal for RNAP binding. Vice versa, a nucleotide spacer be-
tween the 35 and 10 sequences that greatly exceeds or falls
below 17 nt is associated with a reduction in the level of transcrip-
tion or gene silencing.
Antigenic variation is one of the specialized mechanisms
evolved by the syphilis agent to foster immune evasion and per-
sistence in the host (20–22). We have previously shown that tran-
scription of the T. pallidum tprF, tprI, tprE, and tprJ genes is mod-
ulated by promoter-associated poly(G) sequences of various
lengths (23) and may lead to phase variation in these antigens. In
addition, the abundance of similar homopolymeric tracts in theT.
pallidum genome suggested that the use of these elements tomod-
ulate gene transcription might be widespread in this pathogen. In
this study, we focused on the poly(G) tract associated with the T.
pallidum TP0126 gene, originally annotated as residing within the
coding sequence for a hypothetical protein of unknown function
(24). Our data show that the TP0126-associated poly(G) is located
within the gene promoter and that this element varies in length in
vivo during experimental infection in the rabbit model of syphilis
and is involved in transcriptional regulation of TP0126 with a
mechanism consistent with phase variation. In addition, experi-
mental identification of theTP0126 transcriptional start site (TSS)
supports the suggestion that the open reading frame (ORF) is 69
amino acids (aa) shorter than originally annotated and that the
encoded TP0126 protein harbors an NH2-terminal cleavable sig-
nal peptide commonly employed by Gram-negative bacteria to
sort surface-exposed antigen. Evidence that phase variation is of-
ten (although not exclusively) reported to affect expression of sur-
face antigens in bacterial pathogens (14, 19) prompted us to begin
investigating whether TP0126 could be a newly identified putative
surface antigen. We provide in silico evidence that identifies the
shorter TP0126ORF to be a putative homolog ofOmpW, an outer
membrane porin likely involved in transporting hydrophobic
molecules into the outer membrane (25, 26). Circular dichroism
(CD) analysis of recombinant TP0126 showed a -sheet compo-
nent compatible with structural homology between TP0126 and
OmpW. Altogether, these findings suggest that regulation by
phase variation is more widespread in T. pallidum than currently
reported and that TP0126’s possible localization on the T. palli-
dum surface and its role in the biology of this spirochete and syph-
ilis pathogenesis are worthy of further investigation.
MATERIALS AND METHODS
Ethics statement. New Zealand White rabbits were used for treponemal
strain propagation and experimental infections. Animal care was pro-
vided in full accordance with the guidelines in the Guide for the Care and
Use of Laboratory Animals (27), and experimental procedures were con-
ducted under protocols approved by the University of Washington Insti-
tutional Animal Care and Use Committee (IACUC). The protocol num-
ber assigned by the IACUCcommittee that approved this study is 4243.01.
Deidentified sera from human syphilis patients were used in this study,
and this research has been determined by the University of Washington
Human Subjects Division not to meet the federal regulatory definition of
human subjects research.
Strainpropagation, clonal isolate derivation, sample collection, and
nucleic acid extraction. Five T. pallidum subsp. pallidum strains (Bal3,
Chicago, Nichols Seattle, MexicoA, and Sea81-4), two T. pallidum subsp.
endemicum strains (BosniaA and IraqB), T. pallidum subsp. pertenue
strain SamoaD, and Treponema paraluiscuniculi strain CuniculiA were
propagated inNewZealandWhite rabbits bymeans of intratesticular (i.t.)
inoculation as previously described (28). Briefly, spirochetes were ex-
tracted from infected rabbit testicles at peak orchitis following injection of
a maximum of 5  107 bacterial cells per testicle and placed in sterile
saline. Treponemes were collected in sterile 15-ml tubes, taking the nec-
essary precautions to avoid cross-contamination between samples in case
of contemporary harvests. Bacteria were then immediately spun in an
Eppendorf 5810R centrifuge (Eppendorf, Hauppauge, NY) at 1,000 rpm
(equivalent to 250  g) for 10 min to remove rabbit tissue debris, fol-
lowed by transfer of the supernatant to 1.7-ml sterile microcentrifuge
tubes and centrifugation at 12,000 g for 30 min at 4°C (28) to pellet the
treponemes. The pellets were subsequently resuspended in 200 l of 1
lysis buffer (10 mM Tris, pH 8.0, 0.1 M EDTA, 0.5% sodium dodecyl
sulfate [SDS]) if theyweremeant to be used forDNA isolation or in 400l
of phenol-based UltraSpec buffer (Biotex Inc., TX) prior to total RNA
isolation. Table 1 reports the different geographical regions, years, and
anatomical sources of isolation of the strains studied here.
A clonal Nichols strain of T. pallidum subsp. pallidum (Nichols Hous-
ton O) was obtained as previously described (28, 29). This technique,
originally developed to study the antigenic variation of the TprK protein,
was previously shown to be an effective method to obtain treponemal
isolates isogenic for the tprK gene from a heterogeneous population of
cells expressing different TprK variants (22, 29–31). Briefly, to obtain the
TABLE 1 Treponemal strains used in this study
Species Strain name Source Location Yr of isolation
T. pallidum subsp. pallidum Nichols (Seattle and Houston lineages)a Cerebrospinal fluid Washington, DC 1912
Sea81-4b Primary chancre Seattle, WA 1980
Bal3c Blood, congenital Baltimore, MD Circa 1973
MexicoAc Primary chancre Mexico 1953
Chicagoc Primary chancre Chicago, IL 1951
T. pallidum subsp. pertenue SamoaDc Skin Western Samoa 1953
T. pallidum subsp. endemicum BosniaAc Penile ulcer Bosnia 1950
IraqBc Oral mucous patches Iraq 1951
T. paraluiscuniculi CuniculiAc Unknown Baltimore, MD Unknown
a Originally provided by James N. Miller, University of California, Los Angeles, CA, to Sheila Lukehart (Seattle lineage) or to Steven J. Norris (Houston lineage). Nichols Houston
was kindly provided by Steven J. Norris and was used to derive the Nichols Houston O clonal isolate.
b Strain isolated in Seattle, WA, by Sheila A. Lukehart, University of Washington, Seattle, WA.
c Strains provided by Paul Hardy and Ellen Nell, Johns Hopkins University, Baltimore, MD.
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Nichols Houston O strain, a naive rabbit was injected intravenously (i.v.)
with 108 T. pallidum subsp. pallidum (Nichols Houston strain) cells
through the marginal ear vein, and treponemes were allowed to dissemi-
nate and form isolated skin lesions visible on the rabbit shaven back.
Clonality is achieved because each discrete skin lesion is believed to be
seeded by a single treponemal cell that carries a unique tprK sequence (29,
30, 32). Biopsy specimens of isolated skin lesions were minced in 1 ml of
normal rabbit serum (NRS). Following homogenization, approximately
half of the treponemal suspension obtained was injected into a naive re-
cipient rabbit to propagate the clone. After multiplication of the clonal
isolate within the rabbit, treponemes were harvested again and used to
infect three naive rabbits intradermally (i.d.; 106 T. pallidum cells per site)
in multiple sites on their shaven backs. The clonality of the treponemal
inoculum was assessed by sequencing as previously reported (32) and by
fluorescent fragment length analysis (FLA; see below) of the TP0126-
associated poly(G) tract. Biopsy specimens from lesions appearing at the
intradermal injection sites were collected from all infected rabbits weekly
for 3 weeks and minced in 1 lysis buffer for DNA extraction to evaluate
the variation of the poly(G) tract upstream of TP0126 using FLA.
DNA was extracted using a DNA minikit (Qiagen Inc., Chatsworth,
CA) according to themanufacturer’s instructions, with the exception that
50 l of proteinase K (from a 100-mg/ml stock solution) was added and
the sample was incubated overnight at 56°C. After the final elution step in
200 l of molecular-grade H2O, DNA was stored at20°C until needed
for amplification. The protocols used for isolation of total RNA from the
samples in UltraSpec buffer and DNase I treatment to obtain DNA-free
RNA samples prior to reverse transcription were previously reported in
detail (33).
Comparative study of TP0126 sequence and fluorescent fragment
length analysis of the TP0126-associated poly(G) repeat. The full
TP0126 ORF (as originally annotated in the Nichols genome) (24) was
amplified using DNA extracted from all isolates studied here (with the
exception of the Nichols Houston lineage, whose genome was sequenced
twice and whose TP0126 sequence is already available [24, 34]) and se-
quenced to evaluate genetic diversity. Primers and amplicon sizes are
listed in Table 2. For the TP0126 full-length ORF plus 204 and 106 nucle-
otides in the 5= and 3= flanking regions, respectively, amplifications were
performed in a 50-l final volumeusing 2UofAccuPrimePfx polymerase
(Life Technologies, Carlsbad, CA) and 100 ng of DNA template in each
reaction mixture. The mix was also supplied with primers, MgSO4, and
deoxynucleoside triphosphates (dNTPs) at final concentrations of 300
nM each, 1 mM, and 300 M, respectively. Amplifications were carried
out for 45 cycles with denaturation (94°C), annealing (60°C), and exten-
sion (68°C) times of 30 s, 30 s, and 1 min, respectively. The initial dena-
turation (94°C) and final extension (68°C) steps were 10 min each. For
each strain, two independent amplifications were performed using the
same template DNA. Subsequently, amplicons were cleaned of unincor-
porated primers and dNTPs using the ExoSAP-IT reagent (Affymetrix,
Santa Clara, CA). Following spectrophotometric quantification using an
ND-1000 instrument (NanoDrop Technologies, Wilmington, DE), 40 ng
of template was mixed with 25 pmol of one (of four) sequencing primers
(Table 2) designed to ensure complete coverage of both strands. Sanger
sequencing was outsourced (Genewiz, Seattle, WA), but the results were
analyzed in the laboratory using Bioedit software (http://www.mbio.ncsu
.edu/bioedit/bioedit.html). A smaller DNA fragment containing the
TP0126-associated poly(G) repeat was also amplified for FLA. Amplifica-
tion was performed using a 6-carboxyfluorescein (FAM)-labeled sense
primer and an unlabeled antisense primer. A pig-tailed sequence (GTTT
CTT; Table 2) was added to the 5= end of the antisense primer to ensure
uniform addition of nontemplated A overhangs to all amplicons (35).
Amplifications were performed in a 50-l final volume using 0.2 unit of
GoTaq polymerase (Promega Inc., Madison, WI) with 100 ng of DNA
template in each reactionmixture and primers,MgCl2, and dNTPs at final
concentrations of 200 nM, 1.5 mM, and 200 M, respectively. Initial
denaturation (94°C) was for 10 min, while final extension (72°C) was for
30 min. Denaturation (94°C), annealing (60°C), and extension (72°C)
were carried out for 30 s each for a total of 45 cycles. Amplification prod-
ucts were purified using a QIAquick PCR purification kit (Qiagen). Con-
centrations were measured spectrophotometrically, and all samples were
diluted to a 0.2-ng/l final concentration. One microliter of each sample
was mixed with 15.4 l of Hi-Di formamide and 0.1 l of an HD400
carboxy-X-rhodamine (ROX)-labeled DNA size marker (both reagents
were from Life Technologies). Samples were transferred to a 96-well plate
and denatured by incubation at 94°C for 2 min, chilled on ice for 1 min,
and loaded on an ABI 3730xl DNA analyzer (Life Technologies) for sep-
aration by capillary electrophoresis. Electropherogramswere analyzed us-
ing the GeneMapper (version 4.0) software package (Life Technologies);
data on amplicon length (determined by comparison to the length of the
ROX-labeled marker) and intensity (measured as the area under a peak)
were collected to evaluate the relative amounts of amplicons with poly(G)
regions of different lengths within each sample. For each strain, FLA was
performed in triplicate using three independent amplification products
with the same template DNA. For data analysis, the sum of the area un-
derneath all peaks generated by amplicons with the same number of G
residues was divided by the total area underneath all peaks. Data analysis
was performed using analysis of variance (ANOVA), with significance
being set at a P value of0.05, and the Bonferroni correction was applied
for multiple comparisons. Analysis was performed using Prism software
(version 5; GraphPad Software, La Jolla, CA). Amplification of the tprK
gene to assess the clonality of theNicholsHoustonO strainwas performed
as reported previously (36). The primers used are listed in Table 2.
TP0126 transcriptional start site identification. A 5= rapid amplifi-
cation of cDNA ends (RACE) kit (Life Technologies) was used to deter-
mine the TP0126 gene TSS (position	1) and, hence, the location of the
10 and 35 sequences of the TP0126 promoter. 5= RACE was per-
formed on total RNA from theT. pallidum subsp. pallidumNichols Seattle
and Chicago strains following the kit manufacturer’s instructions. For
each strain the procedure was carried on in duplicate using the same
template RNA. Briefly, for the initial reverse transcription step, 1 g of
sample RNAand 2.5 pmol of a first TP0126-specific antisense primerwere
used (Table 2). Subsequent to reverse transcription, 1 l of an RNase
H-T1 mix was added to the tube and the cDNA was incubated for 20 min
at 37°C prior to cDNA purification using the columns and buffers pro-
vided with the 5= RACE kit. Prior to amplification, dC tailing of purified
cDNAwas performed according to the instructions provided with the kit.
All PCRs were performed using 5 l of dC-tailed cDNA in a 50-l final
volume containing 2.5 units of GoTaq polymerase (Promega), 200 M
each dNTP, 1.5 mMMgCl2, and 400 nM each primer (a second TP0126-
specific antisense primer annealing upstream of the one used for first-
strand synthesis and the abridged anchor primer [AAP] providedwith the
kit; Table 2). It was not necessary to perform a nested amplification step.
Cycling parameters included initial denaturation (94°C) and final exten-
sion (72°C) for 10 min each. Denaturation (94°C), annealing (60°C), and
extension (72°C) steps were carried out for 1 min each for a total of 45
cycles. PCR products were purified from agarose gels using the QIAquick
gel extraction kit (Qiagen) and cloned into the pCRII-TOPO TA vector
(Life Technologies) according to the instructions of the manufacturer.
Plasmid DNA was extracted from at least 10 insert-containing colonies
per cloning reaction using a plasmidminikit (Qiagen) and sequencedwith
vector-specific sense and antisense primers. Sequence data were analyzed
using the Bioedit software. Following TSS identification, the region up-
stream of the 	1 nucleotide was analyzed using the BProm program, a
bacterial promoter recognition program that uses an algorithm trained
with recognized 70 signatures, to confirm the initial predictions of the
location of the 35 and 10 sequences and the likelihood that they are
binding sites for the 70 subunit of the RNA polymerase holoenzyme.
TP0126 promoter-GFP reporter assay. TP0126 promoters contain-
ing poly(G) sequences of different lengths were available from a plasmid
library previously generated by amplifying, cloning, and sequencing the
TP0126 region containing the poly(G) repeat from syphilis-causing
Transcriptional Regulation of TP0126
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strains. From this library, TP0126 promoter regions containing poly(G)
regions of 8 to 12 nucleotides were amplified again with primers (Table 2)
designed to place the green fluorescent protein (GFP) reporter gene of the
pGlow-TOPO TA vector (Life Technologies) under the control of the
experimentally identified TP0126 promoter and fuse the TP0126 ATG
with the GFPORF. No promoter regions with 7 or fewer G residues in the
poly(G) tract were found in the library. Thus, to obtain a TP0126 pro-
moter with 7 G residues, a primer (Table 2) was designed to obtain an
amplicon with the poly(G) tract of the desired length so that it could be
cloned into the pGlow-TOPOTAvector. Nichols SeattleDNAwas used as
the template for this amplification. The chemistry of the amplificationwas
identical to that reported for the TP0126 full-length ORF (see above).
Initial denaturation (94°C) and final extension (72°C) were 10 min each,
while denaturation (94°C), annealing (60°C), and extension (72°C) were
carried out for 30 s each for a total of 45 cycles. Amplicons included 18 nt
upstream of the poly(G) tract, predicted to harbor the 35 sequence of
the TP0126 promoter according to the 5= RACE and BProm analyses, and
59 nt downstream of the poly(G), predicted to contain the10 consensus
sequence and a putative ribosome binding site (RBS; GGAG) located 6 nt
upstream of the TP0126 ATG. Amplicons were gel purified to eliminate
the plasmid template and cloned into the pGlow-TOPO TA vector ac-
cording to themanufacturer’s instructions.With the exception of the start
codon, no other TP0126 codons were present in the constructs. Expres-
sion of GFP from these constructs resulted in the addition of 9 extra
amino acids to the actual GFP peptide, encoded by TP0126 ATG, and 8
additional codons already present in the vector sequence. In total, six
TABLE 2 Primers used in this study
Expt Primer namea Sequence (5=¡ 3=)
Amplicon
size (bp)
TP0126 amplification and sequencing
for analysis of genomic diversity
among strains
TP0126-S1 ATGCGGACGCACGACATACC 924b
TP0126-As1 GAGCGGCACGTCCGCGCAA
TP0126-S2 CGCGGACCCGTGGGACACT NAc
TP0126-S3 GGCTGGCTTCAATTATCAGC NA
TP0126-As2 TACCGTCAGTGGCAAGCGGA NA
TP0126-As3 CGCAGTAGTGTCCCACGGGT NA
FLA to evaluate poly(G) variability
and TP0126 5= RACE to determine
TP0126 TSS
FAM-TP0126-S FAM-ACGACATACCCCGCAGTC 275
Pig-TP0126-As GTTTCTTGTGCAGCTCCCCACACTC
RT-TP0126-As GCCTTGAGCACAAGACCGTA NA
RACE-TP0126-As GTGCAGCTCCCCACACTCCCG 154
Abridged anchor primer (AAP) GGCCACGCGTCGACTAGTAC(G)14
Expression of recombinant TP0126
and TP0493 (70) proteins for
ELISA and IVT assay
NT-TP0126-S TGGGACACTACTGCGGCGG 672
NT-TP0126-As TCAGAGGTGGTAGCGAACGT
CT-TP0493-S ATGATGGAGCTGTCACGTAC 1,833
CT-TP0493-As ACTGTCAAGGAAATCCTTCA
TP0493-S2 ATCTGCGTGATATCGGCCAA NA
TP0493-S3 AAAAGCAACTTATGATTGCT NA
TP0493-S4 ATAGAGCAGATAAATAAAGTG NA
TP0493-As2 TATCTGCTCTATCATGTGTAC NA
TP0493-As3 ATCTATCTCCTCTAATTGCA NA
TP0493-As4 TTCCGCGCGTTTGACAGCAA NA
Real-time quantification of TP0126,
GFP, and TP0574 messages
GFPrt-S CTACCTGTTCCATGGCCAAC 263
GFPrt-As TGTGTCCGAGAATGTTTCCAT
TP0126rt-S CGCAAGTGTGCAGTACCATT 201
TP0126rt-As GCCTTGAGCACAAGACCGTA
TP0574rt-S CGTGTGGTATCAACTATGG 313
TP0574rt-AS TCAACCGTGTACTCAGTGC
GFP transcription assay (in E. coli and
in vitro) to evaluate poly(G) effect
on TP0126 transcription
Prom-TP0126-S GGTTCGACAAACAGCCGTGG 85–89d
Prom-TP0126-As CATACCCCGCTCCAACGCCG
Nopro-TP0574-S CGTGTGGTATCAACTATGG 313
Nopro-TP0574-As TCAACCGTGTACTCAGTGC
Lac-S CGCAACGCAATTAATGTGAGT 124
Lac-As CATAGCTGTTTCCTGTGTGAA
Amplification of a TP0126 promoter
with 7 G residues in poly(G) tract
TP0126-7G-PromS GGTTCGACAAACAGCCGTGGGGGGGTAGA 84
Prom-TP0126-As CATACCCCGCTCCAACGCCG
tprK amplification tprK-S TCCCCCAGTTGCAGCACTAT 2,133
tprK-As TCGCGGTAGTCAACAATACCA
a RT-TP0126-As and TP0126rt-AS are identical. TP0574rt-S is identical to Nopro-TP0574-S, and TP0574rt-As is identical to Nopro-TP0574-As.
b With a poly(G) sequence of 9 G repeats.
c NA, not applicable, which indicates sequencing primers or primers used for specific reverse transcription reactions (RT-TP0126-As).
d Depending on the number of G residues.
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different constructs were obtained for the TP0126 promoter, with the
poly(G) repeats in these constructs being 7 to 12 nt long. A construct
containing the lac promoter upstream of the GFP gene was used as a
positive control (the primers are listed in Table 2). As a negative control to
determine background fluorescence, the TP0574ORF fragment amplified
for message quantification purposes (see below for a description of the
quantification of the TP0126 message) and not predicted to harbor a
promoter or a ribosome binding site was inserted upstream of the GFP-
coding sequence in the pGlow-TOPO TA vector. All constructs were se-
quenced onboth strands to verify sequence accuracy and the correct insert
orientation. The constructs were then used to transform Escherichia coli
TOP10 cells (Life Technologies), which do not carry the lacI repressor
gene.
For GFP fluorescence measurements, cells transformed with the vari-
ous constructs were inoculated from a plate into 4 ml of LB-ampicillin
(100 g/ml) broth and grown at 37°C for 4 h. The optical density at 600
nm (OD600) of all cultures was then measured using a biophotometer
(Eppendorf), and cultures were diluted to identical optical densities (0.5
absorbance units [AU]). Subsequently, the OD600 and fluorescence were
recorded in parallel until the cultures reached an OD600 of 2 AU. For
fluorescence readings, 400 l of culture was spun for 4 min at 12,000 g
and resuspended in an equal volume of phosphate-buffered saline (PBS).
Cells were then divided into four wells (100 l/well) of a black OptiPlate-
96F plate (PerkinElmer, Boston, MA) for top fluorescence reading. The
excitation and emission wavelengths were 405 and 505 nm, respectively,
and readings were performed in a Fusion universal microplate analyzer
(Packard, Meriden, CT). The reported data represent the fluorescence
(expressed in arbitrary units) normalized to the optical density of the
culture. Background values obtained from each experiment (using E. coli
cells transformed with the reporter vector containing the TP0574 ORF
fragment) were subtracted from the sample values. Differences in the
levels of fluorescence between cultures were compared using ANOVA,
with significance being set at a P value of 0.05, and the Bonferroni
correction was applied for multiple comparisons. The experiment was
repeated twice to ensure reproducibility.
TP0126 IVT assay. An in vitro transcription (IVT) assay was devel-
oped to further confirm the results of the GFP reporter assay and to in-
vestigate whether the T. pallidum 70 factor initiates TP0126 transcrip-
tion, as predicted by BProm. To obtain templates for the IVT assay, DNA
fragments containing variants of the TP0126 promoter [with 7- to 12-nt-
long poly(G) regions] followed by the GFP gene were excised from the
pGlow-TOPO TA vectors used for the GFP reporter assay (see above).
Each of the vectors was incubated with 10 U of ZraI overnight at 37°C,
purified using the QIAquick PCR purification kit (Qiagen), and then in-
cubated with the NotI restriction enzyme (both enzymes were from New
England Biolabs, Ipswich, MA) overnight at 37°C. As positive and nega-
tive controls, respectively, a lac promoter-GFP fragment and the TP0574-
GFP fragment (the no-promoter control) were also excised. Excised frag-
ments were separated from the vector through gel electrophoresis,
purified using the QIAquick gel extraction kit (Qiagen), and quantitated
spectrophotometrically. Additional reagents includedT. pallidum recom-
binant70 (see below for the expression protocol), E. coli core RNAP, and
E. coli RNAP-70 holoenzyme (both the core RNAP and the RNAP-70
holoenzyme were from Epicenter, Madison, WI). For the actual assay,
performed in a 100-l final volume, 10 pmol of each DNA template was
mixedwith 20l of 5 transcription buffer (0.2MTris-HCl, pH 7.5, 0.75
MKCl, 50mMMgCl2, 0.05%TritonX-100, 0.5Mdithiothreitol), 10l of
10 nucleoside triphosphate mix (20 mM [each] ATP, CTP, GTP, and
UTP), and 5 l of 0.1 U/l of inorganic pyrophosphatase (New England
BioLabs) to prevent precipitation of inorganic pyrophosphate. With re-
gard to the transcriptional machinery (core RNAP and  subunit), each
template DNA was tested under four different conditions: (i) with no
RNAP in the presence of T. pallidum 70 (negative control), (ii) with E.
coli core RNAP alone with no  factors (to determine the level of nonspe-
cific transcription), (iii) with E. coli core RNAP plus E. coli 70, and (iv)
with E. coli core RNAP plus T. pallidum 70. The reaction mixtures were
incubated at 37°C for 2 h. Following incubation, the products were briefly
centrifuged and treated with 10 U of Turbo DNase I (Life Technologies)
according to the protocol provided by the manufacturer. Incubation was
prolonged to a total of 1 h prior to termination using the inactivation
reagent provided with the kit. The IVT assay products were then purified
by phenol-chloroform according to standard protocols (37) and reverse
transcribed using a SuperScript III first-strand synthesis kit (Life Technol-
ogies) and a GFP-specific antisense primer according to the manufactur-
er’s instructions. Reverse transcription products were analyzed by quan-
titative PCR (qPCR) using GFP-specific primers (Table 2) annealing
downstream of the one used for reverse transcription. Amplification and
data collection were carried on using a ViiA-7 real-time PCR system and
Power SYBR green PCRmaster mix (Life Technologies). A GFP standard
was created as described below for the TP0126 standard. Triplicate ampli-
fications were performed for each IVT assay using 3 l of cDNA. Primer
concentration and cycling conditions were as described above for the
TP0126 and TP0574 genes. Results were analyzed using ViiA-7 real-time
PCR software and reported as the number of copies of the GFP message
per microliter of sample. Significance was evaluated using ANOVA, and
the Bonferroni correction was applied for multiple comparisons. Signifi-
cance was set at a P value of0.05.
Quantification of TP0126 message. The TP0126 message levels at
peak orchitis, the time when bacterial harvest occurred, were analyzed
using a relative quantification protocol with external standards. This ap-
proach normalizes the amount of message from a target gene to the
amount of mRNA of a reference gene present in the same sample (in this
case, TP0574, encoding the T. pallidum 47-kDa lipoprotein, an antigen
conserved in all treponemal species, subspecies, and strains used in this
study). To obtain the TP0126 standards, a fragment of the TP0126ORF of
201 nt was amplified from Nichols Seattle DNA and cloned into the pCRII-
TOPO TA vector (Life Technologies). Primers are reported in Table 2.
Amplification was performed in a 50-l final volume using 0.2 units of
GoTaq polymerase (Promega) with 100 ng of DNA template. Final
primer, MgCl2, and dNTP concentrations were 200 nM, 1.5mM, and 200
M, respectively. Initial denaturation (94°C) and final extension (72°C)
were for 10 min each. Denaturation (94°C), annealing (60°C), and exten-
sion (72°C)were carried out for 30 s each for a total of 45 cycles. Following
cloning, the construct was sequenced to exclude the possibility of ampli-
fication errors and linearized using the vector’s EcoRV site. EcoRV (Pro-
mega) digestionwas performed for 12 h at 37°C. The digested plasmidwas
subsequently purified with the QIAquick PCR purification kit (Qiagen),
and the concentration was measured spectrophotometrically to calculate
the plasmid copy number per microliter. A standard curve was generated
by serially diluting (10-fold) the plasmid over a range from 106 to 100
copies/l. To achieve a reliable standard curve, a plasmid standard was
amplified in four replicates for each dilution point over the complete
range. Amplifications and data collection were carried out using the
ViiA-7 real-time PCR system and Power SYBR green PCR master mix
(Life Technologies). The same TP0126 primers used for construction of
the plasmid standard were used for message quantification. To obtain the
template for these amplifications, total RNA from each treponemal strain
was reverse transcribed using a SuperScript III first-strand synthesis kit
(Life Technologies) according to the manufacturer’s instructions and by
using the maximum volume of RNA allowed. Prior to quantitative PCR,
reverse-transcribed samples, along with DNase I-treated and untreated
samples, were checked by qualitative PCR as previously described (33) to
ensure that undigested residual DNA would not affect quantification.
Construction of the TP0574 standard was also previously described in
detail (33). Triplicate amplifications were performed for both the TP0126
and TP0574 genes for each strain analyzed. Three microliters of cDNA
template was used in each reaction. Primers were used at 500 nM each.
Cycling conditions were initial denaturation (94°C) for 10 min, followed
by denaturation (94°C) for 15 s and annealing-extension (60°C) for 1min.
Amplification was followed by a standard melting curve generation step.
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Results were analyzed using theViiA-7 real-timePCR software.Data anal-
ysis was performed using ANOVA, with significance being set at a P value
of 0.05, and the Bonferroni correction was applied for multiple com-
parisons.
Expression of recombinant TP0126 and T. pallidum70. Recombi-
nant TP0126, devoid of its putative signal peptide, was expressed follow-
ing ORF cloning into the pEXP-5-NT TOPO vector (Life Technologies),
which added to the TP0126 coding sequence an additional 22 NH2-ter-
minal amino acids, including the 6His tag. No additional residues were
added at the COOH terminus. Amplification of the TP0126 ORF from
Nichols Seattle strain DNA was performed in our laboratory, as was ORF
cloning into the expression vector according to the manufacturer’s in-
structions and confirmation of the correct sequence and orientation for
expression. Briefly, the TP0126 genewas amplified in a 50-l final volume
using 0.2 unit of GoTaq polymerase (Promega) with approximately 100
ng of DNA template. Primer (Table 2), MgCl2, and dNTP final concen-
trations were 200 nM, 1.5 mM, and 200M, respectively. Initial denatur-
ation and final extension (72°C) were for 10 min each. Denaturation
(94°C), annealing (60°C), and extension (72°C)were carried out for 1min
each for a total of 45 cycles. Protein expression and purification services
were purchased from ProMab Biotechnologies, Inc. (Richmond, CA).
According to their protocol, a starter culture of E. coliRosetta cells (Merck
KGaA, Darmstadt, Germany) carrying the recombinant plasmid was pre-
pared by inoculating 2.0 ml of LB-ampicillin (100 g/ml) broth with a
single E. coli colony carrying the TP0126 transgene and allowed to grow at
37°C in a shaking incubator at 250 rpm until the OD600 reached 1.0 AU.
The starter culture was then diluted to 20ml in fresh broth.When the new
culture again reached 1.0AU, it was then diluted into 2 liters of fresh broth
and split in two 4-liter flasks. When the culture reached an OD600 of 0.6
AU, it was inducedwith IPTG (isopropyl--D-thiogalactopyranoside) at a
final concentration of 1 mM. The cultures were then incubated for 5 h at
30°C and subsequently harvested by centrifugation at 3,500 g for 15min
at 4°C, resuspended in 100 ml of PBS, and centrifuged again. Recombi-
nant TP0126 was purified under denaturing conditions. Following pellet
resuspension in 5 ml of binding buffer (50 mM NaH2PO4, 8 M urea, 10
mM imidazole, pH 8.0) per g of culture weight, the suspension was kept
on ice and sonicated with 100 pulses of 6 s each, with each pulse being
separated by 10-s intervals. Insoluble components were precipitated by
centrifugation at 18,000 rpm for 30 min at 4°C, and the cell lysate was
saved. For affinity chromatography, 2.0 ml of nickel-agarose was pack-
aged into a column 2.5 by 10 cm and washed with 3 column volumes of
molecular-gradeH2O and 6 column volumes of binding buffer. Cell lysate
was then loaded, and the flow was adjusted to 1 ml/min. Unbound pro-
teins were washed using 10 bed volumes of binding buffer, followed by 6
column volumes of wash buffer (50 mM NaH2PO4, 8 M urea, 20 mM
imidazole, pH 8.0). Washing continued until the A280 of the flowthrough
was0.01 AU. Recombinant TP0126 was eluted with 2 ml of elute buffer
(50 mM NaH2PO4, 8 M urea, 300 mM imidazole, pH 8.0). This elution
step was repeated three times in total, and eluates were analyzed for purity
and yield by SDS-PAGE. ForCD, recombinant TP0126was refolded using
a ProFoldin refolding column (Hudson, MA) containing lysophosphati-
dylcholine (5 mM), arginine (150 mM), glycerol (10%), dodecyl
maltoside (0.7 mM), and Tris-HCl (0.1 mM), pH 7.5, according to the
manufacturer’s instructions. Refolded TP0126 was dialyzed against PBS
using a 10-kDa-molecular-mass-cutoff Side-A-Lyzer dialysis cassette
(Pierce Biotechnology Inc., Rockford, IL), and the concentration was
evaluated using a micro-bicinchoninic acid protein assay kit (also from
Pierce). CD spectra (190 to 260 nm) were acquired in triplicate at room
temperature using 0.5mg/ml of recombinant, refolded TP0126 in a Jasco-
1500 high-performance CD spectrometer. CD spectra were analyzed us-
ing the online platform Dichroweb (http://dichroweb.cryst.bbk.ac.uk
/html/home.shtml) and the spectra from buffer alone for background
subtraction.
Recombinant T. pallidum 70 (encoded by the TP0493 gene) was ex-
pressed as a soluble recombinant protein in E. coli using the same protocol
for expression and purification previously used for another T. pallidum 
factor (24, encoded by the TP0092 gene) and the T. pallidum cyclic AMP
receptor protein (CRP) homolog, encoded by TP0262 (38, 39). The
TP0493 gene was amplified from strain Nichols DNA as described above
for the TP0126 gene. The resulting amplicon was directly cloned into the
pEXP5-CT/TOPO expression vector (Life Technologies) according to the
manufacturer’s instructions. A suitable plasmid was selected after assess-
ment of the correct orientation and the accuracy of the insert sequence.
The pEXP5-CT/TOPO vector allows expression of a recombinant protein
without any accessory fusion sequence, with the exception of a carboxyl-
terminal 6His tag preceded by 2 amino acid residues (Lys-Gly).
Humoral response against TP0126 during experimental syphilis
and human infection. Purified recombinant TP0126 in PBS containing
0.1% sodium azide and recombinant TP0574 (the 47-kDa lipoprotein),
purchased from ViroStat (Portland, ME) and used as a positive-control
antigen, were used to coat the wells of a 96-well enzyme-linked immu-
nosorbent assay (ELISA) EIA II Plus microplate (ICN, Irvine, CA). The
plates, containing 0.5 g/well of TP0126 or TP0574 protein in 100 l,
were incubated at 37°C for 2 h and subsequently at 4°C overnight to
induce antigen binding to the test wells. The wells were then washed three
times with PBS, blocked by incubation for 1 h at room temperature with
200l of 3% nonfat milk–PBS per well, and washed again. For each of the
9 strains studied here (Bal3, Chicago, Nichols Seattle, MexicoA, Sea81-4,
BosniaA, IraqB, SamoaD, andCuniculiA), sera from three infected rabbits
were collected at approximately 4 and 12 weeks after i.t. inoculation and
pooled. Pooled sera from three uninfected rabbits were used as a negative
control. To remove antibodies against E. coli antigens, all rabbit sera to be
tested were adsorbed against an E. coli (Rosetta strain) lysate. Ten micro-
liters of each adsorbed pool was diluted 1:20 in 1% nonfat milk–PBS, and
100 l was dispensed into the wells. Sera were incubated overnight at
room temperature. The wells were then washed three times with PBS plus
0.05% Tween 20 (Sigma Inc., St. Louis, MO). As a procedural control, a
mouse anti-6His antibody (Sigma) was used to ensure TP0126 binding
to the plate. Sera from syphilis patients at different stages (three patients
with early latent syphilis and five patients with late latent syphilis), as well
as 12 serum samples from healthy controls, were tested at a 1:20 dilution.
One hundred microliters of secondary antibody (alkaline phosphatase-
conjugated goat anti-rabbit IgG, goat anti-mouse IgG, or goat anti-hu-
man IgG; all fromSigma) diluted 1:2,000 in 1%nonfatmilk–PBSwas then
added to each well, and the plates were incubated for an additional 3 h at
room temperature before repeating the washing step. After addition of 50
l of 1mg/ml para-nitrophenylphosphate (Sigma) to each well, the plates
were developed for 45 min and read at 405 nm on a Multiskan MC plate
reader (Titertek, Huntsville, AL). The mean of the background readings
(obtained from uninfected rabbit sera or healthy human blood donors)
was subtracted from the mean for triplicate experimental wells for each
antigen. Results were analyzed using Student’s t test, with significance
being set at a P value of0.05.
In silico analysis of TP0126 hypothetical protein. The sequence and
structural homology of the predicted protein encoded by the shorter
TP0126ORF to other bacterial proteins was investigated using the BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), I-TASSER (http://zhanglab.ccmb
.med.umich.edu/I-TASSER/), and Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2
/html/page.cgi?id
index) programs. The presence of a cleavable signal
peptide was predicted by use of the SignalP (version 4.1; http://www.cbs
.dtu.dk/services/SignalP/), LipoP (version 1.0; http://www.cbs.dtu.dk
/services/LipoP/), and PrediSi (http://www.predisi.de/) programs.
RESULTS
Comparative study of TP0126 sequence, TP0126 transcrip-
tional start site identification, and analysis of TP0126-associ-
ated poly(G) repeat variability in vivo. The TP0126 ORF was
sequenced to evaluate the genomic diversity among six T. palli-
dum subsp. pallidum strains (Bal3, Chicago, MexicoA, Nichols
Seattle, UW249, Sea81-4), two T. pallidum subsp. endemicum
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strains (BosniaA and IraqB), T. pallidum subsp. pertenue strain
SamoaD, and T. paraluiscuniculi strain CuniculiA. The Nichols
Houston TP0126 sequence was already available (24, 34). T. pal-
lidum subsp. endemicum and T. pallidum subsp. pertenue cause
nonvenereal infections (bejel and yaws, respectively) (40); T.
paraluiscuniculi is the agent of rabbit venereal syphilis and is re-
portedly not infectious to humans, despite the high level of genetic
identity with human-pathogenic treponemes (36, 41, 42).
Nucleotide sequence comparison of the TP0126 ORF (as ini-
tially annotated in the Nichols strain) (24) displayed very limited
sequence diversity in the gene ORF among the analyzed strains
(Fig. 1A). However, upon translation of the annotated sequences,
it appeared that all but three ORFs (from the Nichols Seattle,
Nichols Houston, and BosniaA strains) carried a predicted frame-
shift and a premature stop codon due to a poly(G) repeat of 9 G
residues (versus 10 G residues in the Nichols Seattle, Nichols
Houston, andBosniaA strains; Fig. 1A). This prompted us to iden-
tify the actual TP0126 transcriptional start site (TSS) by 5= rapid
amplification of cDNA ends (RACE) with RNA from the Nichols
Seattle and Chicago strains of T. pallidum subsp. pallidum as the
template. 5= RACE results showed that the TP0126 TSS is located
12 nt downstream of the poly(G) repeat, which, therefore, is not
part of the coding sequence, as originally annotated (24). Using
the verified TSS position, 35 (TTGCAC) and 10 (TAGGAT)
70 signature sequences were located (Fig. 1A) upstream and
downstreamof the poly(G) repeat, respectively, as is often seen for
genes undergoing phase variation (14, 19). The location of the
reported35 and10 sequences was also supported by the bac-
terial promoter identification program BProm (see Materials and
Methods). BProm also predicted the dependence of the TP0126
promoter on the 70 transcription factor.
Sequence translation from the first start codon (ATG) down-
stream of the experimentally identified TSS revealed a highly con-
served putative protein in all isolates, with the exception of 1
amino acid difference at position 112 in T. paraluiscuniculi
TP0126 (Fig. 1B), due to an A-to-G transition at position 538 in
the originally annotated DNA sequence (Fig. 1A). The choice of
this new start codon for TP0126 was supported by the presence of
a putative ribosome binding site (RBS) 6 nucleotides upstream
(Fig. 1A). Within this corrected TP0126 ORF, a single synony-
mous nucleotide change was seen at position 383 of the sequence
in Fig. 1A, where a T is present in all syphilis-causing isolates (with
the exception of MexicoA), while all other subspecies and species
tested harbor aG in this position. Another synonymous change (A
to G) is present at position 641 of the T. paraluiscuniculi sequence
(Fig. 1A).
In vivo variation of length in the TP0126-associated poly(G)
tract. To corroborate the hypothesis of a possible role for poly(G)
in the transcriptional regulation of the TP0126 gene, we investi-
gatedwhether this repeat varied in length in vivowithin each strain
studied here by monitoring changes in the poly(G) region in the
clonal Nichols Houston O isolate over time. For this purpose, we
used a fluorescent fragment length analysis (FLA) method based
on amplification of the poly(G) repeat with a fluorescent primer
and subsequent amplicon separation by capillary electrophoresis
in a genetic analyzer. The results are shown in Fig. 2. Although the
clonal Nichols Houston O isolate used to inoculate rabbits (Fig.
2A, Nichols HO inoculum) was found to carry a clonal tprK gene
(data not shown), this strain showed only a nearly clonal TP0126-
associated poly(G), with no 8-G-residue tracts being identified
(94.1% of promoters had 9 G residues, and 5.9% had 10 G resi-
dues). Promoters with 8 G residues, however, were detected in all
subsequent samples from lesions developing in rabbits infected
with this inoculum.Additionally, significant variability in the pro-
portion of promoters with 9 and 10 G residues was noted in these
samples (Fig. 2A). These results demonstrate that the length of the
TP0126-associated poly(G) region varies in vivowithin an isolate.
When differentT. pallidum strains obtained directly from infected
rabbit tissue at peak orchitis were analyzed, the TP0126-assocated
poly(G) region was found to be variable and range from 8 to 11 nt
in length, although not all lengths were detected in every strain
(Fig. 2B). The Sea81-4 isolate carried a significantly higher pro-
portion of promoters with 8 G residues than all remaining strains.
No significant differences were found among the remaining
strains (Bal3, CuniculiA, IraqB, SamoaD,Chicago, andMexicoA),
where promoters carrying 8 G residues could be detected.
Role of poly(G) length in transcription.To investigate whether
poly(G) repeats of different lengths would affect the activity of the
TP0126 promoter, we adopted an E. coli-based heterologous sys-
tem that allows monitoring of expression of a vector-encoded
GFP reporter gene previously placed under the control of an ex-
ogenous promoter. This approach was previously used by our
group to evaluate the role of similar poly(G) repeats in transcrip-
tion of the tprF, tprI, tprE, and tprJ genes, which also encode T.
pallidum putative outer membrane proteins (OMPs) (23). For
this study, six different TP0126 promoters [with poly(G) regions
ranging in length from 7 to 12 nt] were tested along with positive
and negative controls (the lac promoter and a promoterless re-
porter vector, respectively). The results (Fig. 3A) showed that a
maximal GFP fluorescence signal was detected when the TP0126
promoter carried a poly(G) region of 7 residues. Eight G residues
also induced an elevated fluorescence signal, although it was sig-
nificantly lower than that with the promoter with 7 G residues.
When 9 G residues were present in the promoter poly(G), the
fluorescence signalwas reduced by80% in comparison to that of
the promoterwith 7 or 8G residues; a signalwas undetectablewith
12 residues (Fig. 3A). This result strongly supports the hypothesis
that TP0126 expression is controlled by phase variation. As men-
tioned above, the optimal length for the35/10 spacer is 17 nt.
In the TP0126 promoter, a poly(G) of 7 residues brings the length
of the spacer to exactly 17 nucleotides, which appears to be opti-
mal for transcription. A spacer of 18 nt, however, still allows tran-
scription. It is interesting to note that despite repeated amplifica-
tion and cloning attempts, a poly(G) repeat with 7 G residues
could not be isolated directly from bacterial DNA and instead
needed to be engineered using a synthetic primer (Table 2), which
suggests that TP0126 overexpression may be detrimental to the
microorganism in vivo.
In addition to the use of our heterologous system,we also devised
an in vitro transcription (IVT) assay to confirm the influence of
poly(G) regions of different lengths on the activity of the TP0126
promoter and also to investigate whetherT. pallidum housekeeping
factor 70 would initiate TP0126 transcription, as predicted by
BProm. To do so, the same test and control constructs used in our
E. coli-based heterologous system were mixed in vitro with RNAP
core enzyme saturated with either the recombinant T. pallidum or
E. coli 70 protein to carry out transcription. Assay output was
represented by the number of copies of the GFP transcript per
microliter of reverse-transcribedmRNAgenerated during the IVT
assay reaction, measured by real-time qPCR. Procedural controls
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included IVT assay reactions for all promoters in the absence of
core RNAP and with core RNAP but in the absence of the  sub-
unit. The results (Fig. 3B) were very similar to those obtained in E.
coli, with the highest level of transcription being seen for the
TP0126 promoter carrying a poly(G) of 7 residues and decreasing
transcriptional activity being associated with promoters contain-
ing longer poly(G) regions. As expected from the GFP assay con-
ducted in E. coli, both the E. coli and T. pallidum70 proteins were
able to initiate transcription from the TP0126 promoter at similar
levels. Altogether, these results suggest that variability in the
poly(G) tract within the TP0126 promoter modulates expression
of this gene at the transcriptional level and that the housekeeping
factor 70 is involved in TP0126 transcription. These results con-
firmed that the use of E. coli 70 as a surrogate for T. pallidum 70
is valid, as also suggested by previous IVT experiments with T.
pallidum promoters and the E. coli transcriptional machinery per-
formed by our group (43).
Quantification of TP0126 message in vivo. Differential mRNA
FIG1 Comparative analysis of the TP0126ORF as originally annotated in theT. pallidum subsp. pallidumNichols strain (24) (A) and of the TP0126 hypothetical
protein (B). Only sequences harboring diversity are shown in these alignments. Sequences from syphilis-causing strains (Chicago,MexicoA, andNichols Seattle)
are on top, sequences from endemic treponematosis-causing strains (IraqB and BosniaA) are in themiddle, and the sequence of theT. paraluiscuniculiCuniculiA
strain sequence is at the bottom.Nucleotide differences are shown by a white or a gray background, in contrast to a black background, which identifies conserved
residues. Regulatory elements, including the poly(G) region, putative35 and10 binding sites, transcriptional start site (experimentally identified), predicted
ribosome binding site, and start and stop codons are highlighted in orange. In panel A, omitted sequences for syphilis-causing strains (Bal3 and Sea81-4) are
identical to the Chicago strain sequence. The Nichols Houston strain sequence is identical to the Nichols Seattle strain sequence. TheT. pallidum subsp. pertenue
SamoaD sequence (omitted) is identical to the T. pallidum subsp. endemicum IraqB sequence. Portions of the sequences identical in all strains were omitted and
are indicated by ellipses. In panel B, predicted amino acid sequences for the putative TP0126 protein from theChicago,MexicoA, Bal3, Sea81-4,NicholsHouston,
IraqB, BosniaA, and SamoaD strains are identical to the Nichols Seattle sequence shown. The first 28 aa of the putative TP0126 protein are predicted to be a
cleavable signal peptide (see “In silico analysis of TP0126 hypothetical protein and CD” in Results section).
FIG2 Analysis of theTP0126-associatedpoly(G) region in vivoduring experimental syphilis. (A)Results of FLAof theTP0126-associatedpoly(G) region are shown for
the clonal strainNicholsHoustonO (HO) inoculum and treponemes found in lesions after i.d. infectionwith that inoculum.Data are shown for lesions collected from
three rabbits over a 3-week infection. (B)Results of FLAof theTP0126-associated poly(G) region for nineT. pallidum strains harvested at peak orchitis. *, statistically
significant difference (P 0.05) between the proportion of TP0126promoterswith 8G residues in the Sea81-4 strain compared to the proportion in all remaining
strains. The proportion of TP0126 promoters with 8 G residues was not found to be significantly different among the other T. pallidum isolates.
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levels among strains leading to differential expression of an anti-
gen can be the outcome of several factors, including transcrip-
tional control based on randomly changing cis-acting elements,
such as homopolymeric repeats in promoter regions. To examine
whether this occurs in T. pallidum, a real-time qPCR assay was
developed to quantitate the TP0126message in treponemal strains
at the time of harvest (peak orchitis) from the rabbit host. This
approach normalizes the TP0126 message level to that of the
TP0574 gene (encoding the T. pallidum 47-kDa antigen, a highly
expressed periplasmic lipoprotein), as previously described (33).
Quantification data revealed that TP0126 is variably expressed in
the isolates studied here (Fig. 4). High levels of expression of
TP0126 that were not significantly different among the Sea81-4,
Bal3, and CuniculiA strains and compatible with those of the 47-
kDa antigen were seen. The rank order of strains from the highest
to the lowest transcription levels (Fig. 4) mirrors in part the rank
order of the strains for the proportion of poly(G) repeats carrying
8 G residues (reported in Fig. 2A), suggesting that strains carrying
a higher proportion of 8-G-residue tracts have higher levels of
expression of TP0126.
Humoral response against TP0126 during experimental and
human syphilis spirochete infection. The possibility of variable
degrees of humoral immunity to TP0126 in hosts infected with
Treponema isolates was evaluated by ELISA using recombinant
TP0126 and sera obtained from infected rabbits at 4 and 12 weeks
postinfection. The results of the TP0126 ELISA (Fig. 5A) support
the suggestion that infection with different T. pallidum isolates
leads to differential levels of production of TP0126-specific anti-
bodies. Most of the serum samples reacted positively to the
TP0574 antigen (Fig. 5B). The exceptions were the sera from rab-
bits infected with the Sea81-4 and CuniculiA strains collected at
week 4, which showed reactivity to the antigen significantly lower
than that of sera obtained at the same time point from rabbits
infected with the other strains.
Analysis of sera from human patients with early and late latent
syphilis to assess the presence of a humoral response against
TP0126 revealed that all serum samples had a weak but detectable
humoral response against TP0126 (Fig. 6). All human serum sam-
ples, however, reacted strongly against the T. pallidum TP0574
antigen, used as a control.
In silico analysis of TP0126 hypothetical protein and CD.
The presence of a putative cleavable signal peptide and the struc-
tural homology of the TP0126 protein to other proteins was in-
vestigated using a variety of in silico tools, including the BLAST,
I-TASSER, Phyre2, SignalP, PrediSi, and LipoP programs. All sig-
nal peptide prediction programs agreed on the presence of a signal
peptide with a cleavage site between residues 28 and 29. Although
BLAST searches were unable to identify a TP0126 ortholog in
FIG 3 Analysis of effect of poly(G) length (7 to 12 nt) on TP0126 transcrip-
tion. (A) Fluorescence induced in E. coli TOP10 cells transformed with a
pGlow-TOPO TA vector where GFP transcription is under the control of
TP0126 promoters with poly(G) regions of different lengths. A lac promoter-
GFP construct was used as a positive control. The lac promoter is recognized
by 70, and the E. coli strain used for this assay does not carry the gene that
encodes the LacI repressor. The background fluorescence collected from E. coli
cells transformedwith a pGlow-TOPOTA vector that carries a fragment of the
T. pallidum TP0574 ORF devoid of a promoter was subtracted from the values
for the other samples. *, statistically significant difference (P 0.05). Signals
from 9 G-, 10 G-, and 11 G-GFP constructs were not found to be significantly
different. A signal from the 12 G-GFP construct was undetectable. (B) Results
of the IVT assay using the same constructs employed for the TP0126 promot-
er-GFP assay in E. coli. Three different conditions are shown: transcription
driven by cRNAP alone, cRNAP plus T. pallidum 70, or cRNAP plus E. coli
70. The data output is the number of copies of the GFP transcript per micro-
litermeasured by real-time qPCR. Therewas no transcription in the absence of
cRNAP (data not shown). *, statistically significant difference (P 0.05) when
signals from different constructs are compared. The message levels (white
bars) induced by the 9 G-, 10 G-, 11 G-, and 12 G-GFP constructs were not
found to be significantly different.
FIG 4 Message quantification for TP0126 in treponemal isolates. The number
of TP0126 gene mRNA copies is normalized to 100 copies of the mRNA of the
TP0574 gene (encoding the 47-kDa lipoprotein). In the Sea81-4, Bal3, and
CuniculiA strains, TP0126 expression was significantly higher than that in all
other strains, with the exception of CuniculiA and IraqB TP0126 message
levels. TP0126 expression in IraqB was found to be higher than that in Mexi-
coA, Nichols Seattle, and BosniaA but not SamoaD and Chicago. MexicoA,
Nichols Seattle, and BosniaA exhibited similar transcription levels for TP0126.
Transcription levels roughly matched the percentage of poly(G) repeats carry-
ing 8 G residues (reported in Fig. 2B) in these strains.
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other prokaryotes on the basis of sequence homology, both I-
TASSER and Phyre2 identified TP0126 to be a structural homolog
of E. coliOmpW and Pseudomonas aeruginosaOprG, also a mem-
ber of the OmpW family of proteins. Secondary structure and
disorder prediction by I-TASSER (Fig. 7A) reports an -helix
component of 3.5% (when a protein sequence lacking the signal
peptide is used for analysis), a -barrel component of 49.2%, and
a random coil (RC) component of 47.3%. A similar prediction by
Phyre2, however, reported component proportions of 14%  he-
lix, 70%  barrel, and 16% RC. The I-TASSER confidence (C)
score and TM score were2.52 and 0.42 0.14, respectively. The
C score estimates the quality of the predictedmodels and typically
ranges from 5 to 	2, with a higher C-score value signifying a
model with a high confidence and vice versa. The TM score pro-
vides a scale formeasuring the similarity between two structures; a
TM score of0.5 indicates amodel of correct topology, and a TM
score of0.17 indicates random similarity. Due to the moderate
confidence for this model expressed by I-TASSER analysis, re-
folded recombinant TP0126 (without the signal peptide) was used
to produce circular dichroism (CD) spectra and to gain prelimi-
nary experimental evidence for the TP0126 structure. Analysis of
the CD spectra (Fig. 7B) with the Dichroweb program revealed
proportions of -barrel (43%), -helix (30%), and random coil
(27%) components that are compatible with a -barrel OMP.
DISCUSSION
Although syphilis can easily be diagnosed with traditional and
modern tests (44–46) and effectively treated with penicillin (47),
the continuing high global prevalence of this infection is a strong
argument for the need to deepen our knowledge of syphilis patho-
genesis. Such research efforts will allow syphilis investigators to
understand what mechanisms make T. pallidum such a successful
pathogen able to invade virtually every bodily organ, including the
placenta, and persist for the lifetime of the infected host, in spite of
a robust immune response (48). The knowledge accumulated in
the last decade on T. pallidum variable antigen TprK, for example,
supports a pivotal role for antigenic variation in immune evasion
and pathogen persistence (29, 30, 32).
Phase variation is amechanism that allows reversible and quick
on/off switching of gene expression at the transcriptional or trans-
lational level and is generally mediated by modification of DNA
repeats of various lengths located within a gene promoter or ORF.
In other pathogens, such asN. meningitidis orHelicobacter pylori,
phase variation is strongly associated with expression of genes
involved in adaptation to different environmental conditions, in-
cluding different sites of infection, but also immune evasion and
persistence (14, 15, 49). Whether phase variation has a role in
fostering the ability of T. pallidum to avoid immune clearance,
persist, and perhaps adapt to the diverse microenvironments in
the host is still unclear. However, evidence that transcription of at
least three T. pallidum repeat (tpr) genes encoding putative sur-
face-exposed virulence factors (24, 50) is controlled by phase vari-
ation (23) strongly suggests that this mechanism is also important
in syphilis pathogenesis. A preliminary search for poly(G) se-
quences (of8 residues) in the Nichols strain genome (24) leads
to the identification of 20 such elements that are located upstream
or within T. pallidum ORFs (Table 3) and that have been studied
only partially or not at all (Table 3). Preliminary analysis of the
poly(G) region located within the TP0127 ORF, for example,
showed that this poly(G) tract is variable in length within isolates,
and depending upon the number of G residues present, two alter-
native TP0127 proteins of comparable size but different primary
structure are predicted, as is a third variant with a premature stop
codon that truncates the protein (31). The identification of vari-
able sequence repeats and the analysis of their possible functional
significance based upon their sequence context, for example, al-
lowed Saunders et al. (51) to identify 52 new potentially phase-
variable genes in N. meningitidis, in addition to those previously
recognized. Such findings support the suggestion that in N. men-
ingitidis the role of phase variation in mediating bacterium-host
interactions is likely greater than that which has been appreciated
thus far. The expression of these genes in different combinations
could generate an impressive number of bacterial phenotypic
variants, allowing overall better pathogen fitness in the arena rep-
resented by the infected host. Hence, the identification of ho-
mopolymeric sequences of various lengths in the T. pallidum ge-
nome could provide a simple approach to single out genes with an
important role in virulence.
FIG 5 Humoral reactivity to the TP0126 antigen (A) and the TP0574 antigen
(B) of sera from rabbits infected with different treponemal strains. Sera were
collected at 4 weeks and 12 weeks after rabbit i.t. infection. A mouse anti-
6His monoclonal antiserum was used to confirm TP0126 binding to the
wells of the ELISA plate; the OD405 measured using anti-6His antibody was
3.64 AU. The optical density from sera from uninfected rabbits was used for
background subtraction.
FIG 6 Humoral reactivity of sera frompatients with syphilis at different stages
(primary, secondary, and latent) to the TP0126 protein and the TP0574 anti-
gen (the 47-kDa lipoprotein). A mouse anti-6His monoclonal antiserum
was used to confirm TP0126 binding to the wells of the ELISA plate. The
optical density for sera from uninfected patients was used for background
subtraction. Significance was evaluated using Student’s t test, with significance
being set at a P value of 0.05. *, statistically significant difference between
reactivity to the TP0126 and TP0574 antigens for each group of sera.
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The well-documented role of phase variation in controlling
expression of surface-exposed proteins involved in the host-
pathogen interaction promoted us to investigate whether TP0126
might also be a putative T. pallidum OMP not previously identi-
fied (52, 53). As reported here, in silico analysis and CD spectrum
data indicate that TP0126 exhibits structural characteristics con-
sistent with a -barrel OMP, supporting our hypothesis that
TP0126 is a putative surface antigen. We are currently utilizing
additional approaches to further substantiate these findings, in-
cluding investigating whether anti-TP0126 sera can opsonize T.
pallidum in phagocytosis assays and whether the protein can be
detected on the T. pallidum surface using a gold-labeled anti-
TP0126 serum and electron microscopy, as previously reported
for the TprI antigen (54). In addition, experiments identifying the
location of B- and T-cell epitopes on TP0126 will provide addi-
tional support for our current structuralmodel of the protein (not
shown) and its localization in the pathogen’s outer membrane.
Similar analyses have been used previously in our work on the
TprKprotein, also predicted to have a-barrel structure similar to
that of TP0126, but with a higher number of antiparallel strands
(14 instead of 8) and predicted surface loops (seven instead of
four). For TprK, sera obtained from syphilis spirochete-infected
rabbits contain antibodies that react only with TprK’s putative
surface loops, while T-cell epitopes are confined to amino acid
sequences that form the -strand scaffold (55).
If it is demonstrated that TP0126 is a bona fide OMP, its very
high sequence conservation among T. pallidum isolates and sub-
species makes it an attractive vaccine candidate for syphilis to aid
public health control initiatives targeting this disease (56, 57).His-
torically, the identification of T. pallidumOMPs has been difficult
(58, 59), and ongoing research efforts are using the reverse vaccin-
FIG 7 TP0126 model by I-TASSER (A) and CD spectra of recombinant TP0126 (B). The I-TASSER and Phyr2 predictions of the TP0126 structure are
based on structural homology with the E. coliOmpWporin, a small-barrel protein likely involved in the transport of molecules with a hydrophobic character
into the outer membrane. The proportions of the -barrel, random coil (RC), and -helix components based on I-TASSER prediction are 49.2%, 3.5%, and
47.3%, respectively. Phyr2 predicted higher proportions of the -barrel and -helix components (70% and 14%, respectively) but a lower proportion of the RC
component (16%). The CD spectra of recombinant TP0126 expressed without the putative cleavable signal peptide (but with 22 additional plasmid-encoded
NH2-terminal amino acids), however, are consistent with proportions of -barrel, RC, and -helix components of 43%, 27%, and 30%, respectively.
TABLE 3 T. pallidum genes with associated poly(G) tractsa
Gene no. Putative gene function
Poly(G)
locationb
TP0026 Flagellar motor switch protein 100
TP0041-TP0042c Hypothetical proteins 31
TP0059 Hypothetical protein 	153
TP0067 Conserved hypothetical protein 	24
TP0084 Hypothetical protein 48
TP0107 Liposaccharide biosynthesis protein 307
TP0127 Hypothetical protein 	341
TP0136 Fibronectin-binding protein 	532
TP0193 30S ribosomal protein S19 9
TP0216 Heat shock protein 70 	60
TP0230 Primosomal protein N 	942
TP0257 Protein D, glycerophosphodiester
phosphodiesterase
	29
TP0279 30S ribosomal protein S1/cytidylate kinase 	7
TP0347 Hypothetical protein 	99
TP0379 Preprotein translocase subunit 70
TP0479 Hypothetical protein 	95
TP0497 Hypothetical protein 	478
TP0697 Hypothetical protein 	27
TP0798 MetG, methionyl-tRNA synthetase 	826
TP0860 Hypothetical protein 	78
a Only poly(G) tracts of8 residues are listed. A search was performed using the T.
pallidum subsp. pallidum Nichols genome (21).
b Location indicates the position of the first poly(G) residue in relation to the gene
annotated start codon. A negative value indicates that the poly(G) tract is located
upstream of the gene ATG. A positive value indicates that the poly(G) tract is within the
gene ORF.
c TP0041 is a 40-aa-long ORF and might not be real.
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ology approach (60, 61) to identify novel vaccine candidates for
syphilis: this approach includes the use of in silico analysis of avail-
able T. pallidum genomes to identify hypothetical proteins con-
taining sequence or structural homology to known bacterial
OMPs (53, 54); functional activities characteristic of OMPs, such
as attachment of T. pallidum putative surface antigens to host
components (62–65); or the ability of monospecific antibodies to
opsonize viableT. pallidum cells (20, 66). Evidence, reported here,
that during natural infection in humans TP0126 is a weak target
for the humoral immune responsemight simply reflect the limited
immunogenicity of this antigen in vivo, possibly due to low ex-
pression, but it certainly supports the suggestion that, like in rab-
bits, this antigen is expressed by the pathogen during natural in-
fection and could therefore represent a target on the pathogen’s
surface. Future protection and opsonophagocytosis studies using
a specific anti-TP0126 antiserumwill elucidate whether immunity
against this protein might facilitate clearance of T. pallidum from
early lesions, while T-cell proliferation assays will be used to in-
vestigate whether TP0126 is also a target of the host cellular im-
mune response.
The characterization of the poly(G) tract within the TP0126
promoter and its involvement in transcriptional regulation and
phase variation not only call for additional work to characterize
the TP0126 location, structure, and function but also highlight the
possibility that ORF annotation in T. pallidum by computational
gene finding might be subject to errors. Using TP0126 as an ex-
ample, the original annotation suggested that the hypothetical
protein was much larger than it likely is. Thus, despite the impor-
tant contributions provided by gene annotation pipelines, it is
necessary to corroborate in silico predictions with transcriptional
data. Again, in the case of TP0126, this approach led to the iden-
tification of the gene’s putative start codon and to the prediction
of a cleavable signal peptide previously hidden by the 68 addi-
tional NH2-terminal residues in the original TP0126 annotation
(24). Annotation issues can be partially addressed by comparative
analysis of available T. pallidum genomes. The Nichols strain of T.
pallidum subsp. pallidum, for instance, was sequenced twice (34)
due to the high number of sequencing and annotation errors
found in the first genome sequence published in the late 1990s (24,
67). Comparison of the TP0126 ORF between the new and old
genomes reveals that in the resequenced Nichols strain, due to the
presence of fewer residues within the poly(G) repeat, the TP0126
putative sequence is identical to the one proposed here. Such in-
formation was unavailable at the time that our work on TP0126
was under way. This difference in the length of the poly(G) tract
between the two sequencing efforts likely reflects the most com-
mon population in each bacterial harvest.
Our data show that TP0126 transcription can be initiated in
vitro by the housekeeping factor 70, suggestive of an important
function for this protein in vivo in T. pallidum. This conclusion is
also supported by the complete sequence conservation of this an-
tigen among T. pallidum isolates (a single nonsynonymous nucle-
otide change was identified in the ORF of the related species T.
paraluiscuniculi). Currently, the only known OmpW function is
to serve as a receptor for colicin S4 (68), and the possibility that
TP0126 serves a similar function in T. pallidum today appears to
be extremely unlikely. Recent data on the function of OmpW ho-
mologs in other organisms suggest that members of this protein
familymay be involved in bacterial adaptation to various environ-
mental stresses. Expression of OmpW from Vibrio cholerae was
found to be affected by culture conditions, such as oxygen and
nutrient availability, temperature, and salinity (69), while in Sal-
monella enterica serovar Typhimurium, OmpW expression has
been associated with drug resistance (70, 71), perhaps suggesting
an efflux pump mechanism that might also function in osmoreg-
ulation. Further characterization of the TP0126 protein will per-
haps highlight functional similarities between the roles of OmpW
in other pathogens and the role of TP0126 in T. pallidum biology.
The work described above, however, indicates the possibility of a
multifaceted role for this protein in helping pathogens deal with
environmental stresses and, possibly, nutrient acquisition. In this
sense, the crystal structures of E. coli OmpW (25) and the P.
aeruginosaOmpWhomolog OprG (26) are partially illuminating.
According to the results of Hong et al. (25), who elucidated the E.
coliOmpW structure, the most unusual and interesting feature of
the OmpW channel is the hydrophobic character of the -barrel
interior, considering that porins typically have hydrophilic chan-
nels filled with water (72–74). The OmpW channel, therefore,
would be implicated in the transport of molecules with a hydro-
phobic character yet to be identified. The E. coli OmpW crystal
structure also suggests the hypothesis thatmolecules able to access
the OmpW channel would be directly delivered into the hydro-
phobicmoiety of the outer leaflet of the outermembrane, due to a
putative channel exit embedded into the membrane (25). This
peculiarity would allow the porin substrate to avoid the hydro-
philic periplasmic space. Similar findings were later reported for
the P. aeruginosa OprG by Touw et al. (26). Whether TP0126
might be the transporter that mediates the acquisition of fatty
acids (one of the many macromolecules that the syphilis agent is
unable to synthesize but must scavenge from the host) in T. palli-
dum has yet to be shown, but it certainly appears to be an intrigu-
ing working hypothesis.
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